Quick Answer
Jasper Therapeutics, Inc. reported Shares Outstanding of 28.00 million shares for fiscal year 2025.
Jasper Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 28.00M | +86.4% |
| 2024 | 15.02M | +34.6% |
| 2023 | 11.16M | +193.4% |
| 2022 | 3.80M | -90.0% |
| 2021 | 37.86M | +1266.3% |
| 2020 | 2.77M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 27.98M | +86.5% | +72.5% |
| June 30, 2025 | 16.22M | +7.4% | +8.0% |
| March 31, 2025 | 15.02M | -0.4% | +0.0% |
| December 31, 2024 | 15.02M | +34.6% | +0.1% |
| September 30, 2024 | 15.00M | -86.5% | -0.7% |
| June 30, 2024 | 15.11M | -86.4% | +0.1% |
| March 31, 2024 | 15.09M | -86.2% | +35.1% |
| December 31, 2023 | 11.16M | -70.7% | -89.9% |
- Jasper Therapeutics, Inc. showed an increase of +86.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Jasper Therapeutics, Inc.’s shares outstanding has grown by 910.5% (from 2.77 million shares to 28.00 million shares).
- The most recent figure is from Jasper Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: